(ACRS) Aclaris Therapeutics complete technical analysis [charts+indicators] | Buy/Sell Aclaris Therapeutics | (ACRS) share price targets
Complete technical analysis of Aclaris Therapeutics (ACRS) by charts plus indicators, forecast predictions and share price targets for Aclaris Therapeutics (ACRS)
Aclaris Therapeutics trades in USA in Health Care sector.
Showing technical analysis as on 2024-12-17 View latest technical analysis
10 day averaged volume of Aclaris Therapeutics is 1354237
Date | Daily Closing Price | Open | High | Low | Volume |
17 Tue Dec 2024 | 3.26 | 3.00 | 3.29 | 2.91 | 1.073 times |
16 Mon Dec 2024 | 3.02 | 3.20 | 3.26 | 2.99 | 0.775 times |
13 Fri Dec 2024 | 3.22 | 3.16 | 3.35 | 3.14 | 0.582 times |
12 Thu Dec 2024 | 3.27 | 3.53 | 3.57 | 3.26 | 0.504 times |
11 Wed Dec 2024 | 3.54 | 3.64 | 3.64 | 3.38 | 0.598 times |
10 Tue Dec 2024 | 3.63 | 3.93 | 4.00 | 3.61 | 0.512 times |
09 Mon Dec 2024 | 3.88 | 3.97 | 4.03 | 3.77 | 0.624 times |
26 Tue Nov 2024 | 3.63 | 3.93 | 4.15 | 3.63 | 1.475 times |
26 Tue Nov 2024 | 3.63 | 3.93 | 4.15 | 3.63 | 1.475 times |
25 Mon Nov 2024 | 3.99 | 4.11 | 4.23 | 3.86 | 1.247 times |
My analysis of stock is bearish for shortterm, and stock might move down till 2.7 or till 1.8. Use a stoploss of 3.34 and if the stock hits stoploss, then it can shoot up till 4.02
Share price targets for Aclaris Therapeutics (ACRS)
Target Type | Value |
Downside Target | 1.12 |
Downside Target | 1.22 |
Downside Target | 1.39 |
Downside Target | 1.77 |
Downside Target | 1.94 |
Downside Target | 2.29 |
Downside Target | 2.91 |
Downside Target | 3.14 |
Upside Target | 3.29 |
Upside Target | 3.63 |
Upside Target | 4.03 |
Upside Target | 4.15 |
Upside Target | 4.23 |
Upside Target | 5.17 |
Intraday share price targets for Aclaris Therapeutics (ACRS)
Target Type | Value |
Downside Intraday Target | 3.02 |
Downside Intraday Target | 2.77 |
Upside Intraday Target | 3.4 |
Upside Intraday Target | 3.53 |
Downside Intraday Target | 3.15 |
Weekly technical analysis of Aclaris Therapeutics (ACRS)
Date | Weekly Closing Price | Open | High | Low | Volume |
17 Tue Dec 2024 | 3.26 | 3.20 | 3.29 | 2.91 | 0.655 times |
13 Fri Dec 2024 | 3.22 | 3.97 | 4.03 | 3.14 | 1.913 times |
26 Tue Nov 2024 | 3.63 | 3.93 | 4.15 | 3.63 | 0.542 times |
26 Tue Nov 2024 | 3.63 | 4.11 | 4.23 | 3.63 | 0.037 times |
22 Fri Nov 2024 | 3.80 | 2.43 | 5.17 | 2.29 | 17.358 times |
Price has moved up this week, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming weeks.
Monthly technical analysis of Aclaris Therapeutics (ACRS)
Date | Monthly Closing Price | Open | High | Low | Volume |
17 Tue Dec 2024 | 3.26 | 3.97 | 4.03 | 2.91 | 0.054 times |
26 Tue Nov 2024 | 3.63 | 1.81 | 5.17 | 1.77 | 7.415 times |
31 Thu Oct 2024 | 1.81 | 1.16 | 1.94 | 1.12 | 2.813 times |
30 Mon Sep 2024 | 1.15 | 1.16 | 1.22 | 1.12 | 0.572 times |
Scroll below to view daily charts
Price has moved down this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Aclaris Therapeutics (ACRS)
Price action analysis of Aclaris Therapeutics ( (ACRS) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Aclaris Therapeutics ( (ACRS) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Aclaris Therapeutics ( (ACRS) ) based on a short to mid term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
Price action analysis of Aclaris Therapeutics ( (ACRS) ) based on a mid to longer term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Aclaris Therapeutics stock for short term is SELL. Signal strength is Weak and stock is gaining momentum.
MACD generated a SELL signal for Aclaris Therapeutics in short term but the sell signal is initial and weak.
Aclaris Therapeutics Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of green color and prices are in or below the green cloud Prices appear to be moving up
CCI has generated a buy signal for Aclaris Therapeutics in short term but BUY signal is weak.
RSI is generating a BUY signal in short term but buying is losing momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Aclaris Therapeutics is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 3.55 and Aclaris Therapeutics (ACRS) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Aclaris Therapeutics (ACRS) stock. Volume based technical analysis of Aclaris Therapeutics (ACRS) stock is negative.
Aclaris Therapeutics Stock has given negative returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Aclaris Therapeutics ( (ACRS) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Aclaris Therapeutics ( (ACRS) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Aclaris Therapeutics ( (ACRS) ) based on a short to mid term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
Price action analysis of Aclaris Therapeutics ( (ACRS) ) based on a mid to longer term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Aclaris Therapeutics stock for short term is SELL. Signal strength is Weak and stock is gaining momentum.
MACD generated a SELL signal for Aclaris Therapeutics in short term but the sell signal is initial and weak.
Aclaris Therapeutics Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of green color and prices are in or below the green cloud Prices appear to be moving up
CCI has generated a buy signal for Aclaris Therapeutics in short term but BUY signal is weak.
RSI is generating a BUY signal in short term but buying is losing momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Aclaris Therapeutics is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 3.55 and Aclaris Therapeutics (ACRS) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Aclaris Therapeutics (ACRS) stock. Volume based technical analysis of Aclaris Therapeutics (ACRS) stock is negative.
Aclaris Therapeutics Stock has given negative returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.